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Abstract
Background: HIV testing and receipt of HIV test results among individuals with substance use disorders is less than
optimal. We examined rates and correlates of HIV testing and receipt of test results in one of the largest public
addiction health services systems in the United States.
Methods: The study included 139,516 adult clients in treatment between 2006 and 2011. We used logistic
regression models to examine associations between predisposing, enabling, and need factors and two dependent
variables, HIV testing rates and receipt of test results. Associations were considered statistically significance at
p < .01.
Results: We found that 64 % of clients reported being tested for HIV, of whom 85 % reported receiving their test
results. Likelihood of being tested was positively associated with being female, a minority, homeless, employed,
having prior treatment episodes, comorbidities, injection drug use, or a history of mental illness. It was negatively
associated with alcohol or marijuana as primary drug. Receipt of test results was more likely among clients on
medication (methadone or buprenorphine) or whose method of drug use was smoking, inhalation, or injecting; it
was less likely among older clients and those with more outpatient psychiatric visits.
Conclusions: Findings from this study may inform strategies and targeting of population groups to improve HIV
testing practices and ultimately increase awareness of infection status among clients of addiction health services.
Keywords: HIV testing, Receipt of HIV test results, Addiction health services, Substance use disorder treatment
Introduction
More than 1.2 million people in the United States are
living with HIV, with an estimated incidence of 50,000
infections each year [1]. HIV prevalence among individ-
uals with substance use disorders, particularly persons
who inject drugs (PWID), is high compared to the gen-
eral population [2, 3]. Recent data showed that only
49 % of PWID reported ever been tested [4]. For individ-
uals infected with HIV to benefit from antiretroviral
therapy, they must be tested and diagnosed, receive re-
sults of their HIV status, be linked to HIV medical care,
receive treatment, remain continuously engaged in HIV
care, and adhere to treatment [5–11]. HIV testing is
necessary to set this HIV care cascade in motion and ad-
dress the HIV burden, but testing alone is not sufficient.
Clients tested for HIV must also be made aware or in-
formed of their infection status. The Centers for Disease
Control and Prevention (CDC) has estimated that nearly
16 % of HIV positive individuals in the United States are
unaware of their infection status [12]. Knowledge of
one’s infection status may lead to reductions in risky be-
haviors associated with transmission of the virus. Indeed,
individuals who test negative and receive posttest coun-
seling may also adopt risk-reduction behaviors that may
prevent HIV infection.
Although individuals with substance use disorders are
at higher risk of HIV infection, the availability of testing
and receipt of test results is less than optimal [13, 14].
The CDC therefore recommends routine HIV testing for
risk groups, including individuals with substance use
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disorders [15]. Yet, less than half of substance use disorders
treatment programs in the nation offer HIV testing to
their clients [16, 17]. Few studies have examined multi-
component factors associated with testing and receipt of
test results; particularly factors associated with charac-
teristics of clients and substance use disorder treatment
programs [14]. The purpose of the current study was to
examine the rates and correlates of HIV testing and re-
ceipt of HIV test results among clients receiving treatment
services in one of the largest publicly funded addiction
treatment systems in the United States (Los Angeles
County, California).
The Gelberg-Anderson Behavioral Model for Vulner-
able Populations informed our conceptualization of this
study [18]. The model is an extension of the Anderson
Behavioral Model, which describes the relationships
among predisposing, enabling, and need factors that ex-
plain health services use in the general population. Pre-
disposing factors include demographic and other
personal characteristics and health care social structures
that influence the likelihood of obtaining care. These
factors are often present before illness (e.g., gender, age,
education). Enabling factors refer to personal, family,
and community resources that support or are influential
to obtaining health services. Enabling factors serve as fa-
cilitators of health services use and also include employ-
ment status, number of medical visits, and insurance
status. Need factors generally refer to the need for health
services, whether actual or perceived, and conditions of
special relevance to the population of interest that mo-
tivate individuals to seek needed health care services
[19–23]. Clinical evaluation of patients and personal
practices may also affect an individual’s vulnerability sta-
tus and are considered a measure of need. Specifically,
factors such as injection drug use, mental illness, or
hepatitis C virus (HCV) infections often serve as the
motivation or reason for obtaining health services. The
Gelberg-Anderson model has been extensively applied
to HIV testing and receipt of test results among individ-
uals who are homeless or have serious mental illness
[24–26]. However, there is limited empirical information
about the predisposing, enabling, and need factors that
may explain HIV testing and receipt of test results in
publicly funded addiction treatment.
Using the Gelberg-Anderson model and findings from
prior research on HIV testing practices; we examined the
relationship between client and program factors and the
receipt of HIV-related services (i.e., rates and predictors of
HIV testing and receipt of test results). We expected that
predisposing factors (e.g., homelessness) would be nega-
tively correlated with HIV testing and receipt of test re-
sults because of clients’ main priorities of food and shelter,
as well as inconsistent delivery of care to homeless indi-
viduals documented in the literature [27]. We expected
that enabling factors (e.g., prior treatment episodes) would
be positively associated with HIV testing and receipt of
test results. For example, because of greater exposure to
the health care system, clients may be more adept at
navigating the system and have increased opportunities
for HIV testing and receipt of results. Finally, we expected
that need factors (e.g., HCV diagnosis, injection drug use)
would be positively associated with HIV testing and
receipt of test results. These clients may have had experi-
ences that positively influenced their awareness of risk
factors for HIV and would thus be more motivated to
obtain health services.
Hypothesis 1: Predisposing factors, such as homeless-
ness, would be associated with lower odds of (a) HIV
testing and (b) receipt of HIV test results.
Hypothesis 2: Enabling factors, such as prior treatment
episodes, would be associated with higher odds of (a)
HIV testing and (b) receipt of HIV test results.
Hypothesis 3: Need factors, such as HCV diagnosis,
would be associated with higher odds of (a) HIV testing
and (b) receipt of HIV test results.
Methods
Sampling frame and data collection
This study analyzed a subset of data from 2006 to 2011
from the Los Angeles County Participant Reporting Sys-
tem (LACPRS). This database includes data from all
publicly funded substance abuse treatment programs in
the most populous county in the United States [28]. This
ongoing systemwide evaluation database captures the
treatment experience and immediate outcomes of low-
income racially and ethnically diverse clients. Of the 141
items in the LACPRS, more than half are standardized
scales and questions related to admission, discharge, and
health derived from state (California Outcome Measure
System) and federal (Treatment Episode Data Set) meas-
urement systems.
Client data in LACPRS are collected during personal
interviews at intake and discharge for most individuals.
Through the use of standardized instruments, coun-
selors collect information on five major domains: em-
ployment status, legal status, substance use profile,
substance use history, and medical and psychological
status. The collection form includes 10 items from the
Addiction Severity Index [29] and the Drug Abuse
Reporting Program [30, 31]. These scales have been
shown to be reliable measures of substance abuse sever-
ity [32], particularly among diverse populations [33],
allowing for assessment of client reports from intake to
discharge.
Client data used in this study represented 139,516 treat-
ment episodes collected from July 1, 2006, to December
30, 2011. We limited the analysis to outpatient programs
because they represent the most common treatment
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option in Los Angeles County, accounting for more than
70 % of all admissions [34]. Only clients who were admit-
ted and discharged within the same year were included to
obtain accurate estimates, due to data coding issues with
clients who stayed beyond one calendar year.
The University of Southern California Institutional
Review Board reviewed and approved the study.
Dependent variables
We examined two dependent variables related to HIV
services received on- or off-site. Clients were asked at
admission and discharge if they had been tested for
HIV/AIDS on- or off-site and, if so, whether they had
obtained the corresponding results at admission or
discharge. We defined two dichotomous dependent
variables based on these questions. For HIV testing we
used two items: (a) tested for HIV/AIDS on- or off-site
at admission (prior to entering treatment) and (b)
tested for HIV/AIDS on- or off-site at discharge (while
in treatment). For obtaining results, we relied on one
item asked of those tested for HIV/AIDS: (a) received
result of HIV/AIDS test, reported at admission or
discharge. Note that respondents reported being tested
for HIV/AIDS prior to and during treatment, but the
data did not allow us to differentiate whether testing
was provided on- or off-site. We considered all poten-
tial outcomes: testing and receipt of results at admis-
sion only, discharge only, both, or neither. We did not
find differences between individuals tested or individ-
uals who received test results at admission versus
discharge (p > .05).
Independent variables
Predisposing variables
The following demographic and social structure charac-
teristics were included in our models: sex, age, race and
ethnicity, education, and homelessness, measured by
self-reports regarding current housing situation. We also
included source of referral to an addiction health ser-
vices program; number of days spent in jail or prison
during the previous 30 days (criminal activity); and par-
ticipation in any social support recovery activities, such
as 12-step meetings or interaction with family members
or friends supportive of recovery, during the previous
30 days (recovery support). Categories of independent
variables, including enabling and need factors, are pre-
sented in Table 1.
Enabling variables
We included clients’ employment status at admission,
number of days on a waiting list before being admitted
to the treatment program, and treatment type (i.e.,
outpatient, methadone, or residential treatment). Stud-
ies have shown that type of treatment program is
associated with the availability of preventive services
such as HIV and HCV testing [13, 35]. We also in-
cluded variables indicating whether a patient had prior
treatment episodes, received medication for substance
abuse, received outpatient and inpatient health services,
and received substance abuse treatment, medical, and
psychiatric services.
Need variables
Need factors of special relevance to substance abuse
populations included in the analysis were clients’ pri-
mary drug of choice, number of days of primary drug
use during the previous 30 days, and primary method of
drug use [36]. The frequency of injection drug use is as-
sociated with transmission of HIV [37, 38]. Hence, we
included a variable measuring the number of days dur-
ing which a client injected drugs during the previous
30 days. Last, whether a client had been diagnosed with
a sexually transmitted disease or HCV was included be-
cause it related to modes of transmission and coinfec-
tion rates [39–42].
Data analysis
We used univariate statistics to describe client charac-
teristics and summarize rates of HIV testing and receipt
of HIV test results. Chi-square tests were performed
for categorical variables and t-tests for continuous
variables. We then conducted parallel bivariate and
multivariate logistic regressions, which corresponded to
the two dependent variables. Bivariate analysis exam-
ined associations between predisposing, enabling, and
need factors and dependent variables. Multiple random
effect logistic regression was conducted to identify
independent predictors of HIV testing and receipt of
test results. We used a backward elimination strategy
to determine the most parsimonious set of variables
significant at p < .05. These variables were included in
the final models. Due to relative large sample size, we
focused our interpretation of results on factors associ-
ated with HIV testing or receipt of HIV test results at
the statistical significance level of p < .01 and present
99 % confidence intervals. Results are presented as odds
ratios (OR), with which the relationship between
exposure (independent variable) and an outcome (e.g.,
HIV testing) are compared to no exposure. When this
relationship is positive, we reported higher odds
(OR > 1) and lower odds (OR < 1) when the relationship
is negative. To account for the hierarchical structure of
the data, which refers to the nesting of clients in
programs, we used the CLUSTER option in the main
function LOGIT of Stata. All analyses were performed
using Stata/SE Version 12.
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Table 1 Factors associated with HIV testing and receipt of test results among clients in addiction health services
Full sample Tested for HIV Received HIV test results
N = 139,516 n = 89,383 n = 76,392
M (SD) or % M (SD) or % M Diffa pb M (SD) or % M Diffc pb
Predisposing factors
Age 36.13 (12.51) 36.81 (11.51) 2.18 < .001 36.78 (11.46) 1.73 < .001
Days incarcerated 1.99 (6.61) 2.28 (7.07) 0.71 < .001 2.29 (7.09) 0.55 < .001
Recovery support 3.73 (8.24) 4.78 (9.13) 2.76 < .001 4.99 (9.31) 2.70 < .001
Gender
Female 0.35 0.39 < .001 0.39 < .001
Male 0.64 0.61 0.61
Race
White 0.34 0.36 < .001 0.36 < .001
Black 0.23 0.23 .047 0.23 < .001
Latino 0.38 0.37 < .001 0.36 < .001
Asian 0.05 0.05 < .001 0.05 < .001
Education
Less than high school 0.08 0.06 < .001 0.06 < .001
High school 0.75 0.74 < .001 0.74 < .001
College or higher 0.17 0.20 < .001 0.20 < .001
Homeless 0.24 0.29 < .001 0.28 < .001
Referral
Self 0.39 0.39 .072 0.39 .001
Community 0.13 0.11 < .001 0.11 < .001
Proposition 36 0.21 0.21 < .001 0.22 < .001
Drug court 0.08 0.08 < .001 0.09 < .001
Social services 0.19 0.20 < .001 0.20 < .001
Enabling factors
Days on waiting list 3.07 (9.26) 3.42 (8.95) 0.75 < .001 3.21 (8.58) 0.11 .043
Prior treatment episodes 1.66 (3.58) 1.95 (3.70) 0.84 < .001 1.97 (3.62) 0.73 < .001
Outpatient medical visits 0.15 (1.58) 0.18 (1.74) 0.07 < .001 0.17 (1.66) 0.04 < .001
Outpatient psychiatric visits 0.22 (2.00) 0.24 (2.05) 0.04 < .001 0.24 (2.03) 0.02 .092
Treatment type
Outpatient 0.49 0.42 < .001 0.43 < .001
Methadone 0.04 0.02 < .001 0.03 < .001
Residential 0.46 0.55 < .001 0.54 < .001
Employed at admission 0.12 0.12 .212 0.12 < .001
Medication
None 0.81 0.79 < .001 0.80 < .001
Methadone/LAAM 0.06 0.05 < .001 0.06 .429
Buprenorphine 0.64 0.01 .927 0.01 .179
Other 0.11 0.15 < .001 0.13 < .001
Need factors
Days of primary drug use 11.19 (12.49) 11.65 (12.65) 1.18 < .001 11.30 (12.52) 0.41 < .001
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Results
Full sample
Approximately 139,516 clients of addiction health ser-
vices programs in Los Angeles County were included in
the analysis. Nearly 28 % of clients reported more than
one treatment episode, with an average of 1.8 treatment
episodes for the full sample. More than half of the total
final sample reported being tested for HIV during their
time in treatment (64 %). Among those tested, 85 % re-
ported that they received their test results. About 65 %
of the full sample was male, with Blacks and Latinos ac-
counting for 60 %. Nearly 24 % self-reported as being
homeless and the majority of clients were self-referred
to treatment (39 %). Most of the clients in the sample
were not receiving pharmacotherapy (81 %). Metham-
phetamine (25 %), followed by alcohol (22 %), was the
primary drug of choice in the study sample. Approxi-
mately 16 % of clients injected drugs. HCV and sexually
transmitted disease (STD) diagnosis in the sample was




Compared to the full sample, the subsample that re-
ported HIV testing had a higher proportion of women,
Whites, college-educated individuals, homeless individ-
uals, and those referred by social services (see Table 1,
bivariate analysis). Multivariate analysis (Table 2) showed
no support for Hypothesis 1a, i.e., predisposing factors
were not associated with lower odds of HIV testing. The
odds of HIV testing were higher among women than
men (OR = 1.527, 99 % CI = 1.277, 1.826) and among
Blacks and Latinos compared to Whites (OR = 1.299,
99 % CI = 1.039, 1.623 and OR = 1.126, 99 % CI = 0.987,
1.285, respectively). Compared to clients without a col-
lege education, those with a college education reported
higher odds of HIV testing (OR = 1.991, 99 % CI = 1.613,
2.457) after adjusting for other explanatory variables.
Additionally, the odds of HIV testing were higher among
clients who were homeless (OR = 1.414, 99 % CI = 1.161,
1.724); received a referral from Proposition 36 (court re-
ferral to treatment instead of incarceration; OR = 1.388,
Table 1 Factors associated with HIV testing and receipt of test results among clients in addiction health services (Continued)
Days of injection drug use 3.35 (9.11) 3.65 (9.37) 1.28 < .001 3.39 (9.05) 0.48 < .001
Primary drug
Heroin 0.17 0.19 < .001 0.18 < .001
Alcohol 0.22 0.21 < .001 0.21 < .001
Methamphetamine 0.25 0.27 < .001 0.28 < .001
Cocaine or crack 0.16 0.17 < .001 0.18 < .001
Marijuana or hashish 0.14 0.10 < .001 0.10 < .001
Other 0.05 0.06 < .001 0.06 < .001
Method of drug use
Oral 0.27 0.26 < .001 0.26 < .001
Smoking 0.51 0.50 < .001 0.51 < .001
Inhalation 0.06 0.06 < .001 0.06 < .001
Injection 0.16 0.18 < .001 0.17 < .001
Other 0.07 0.01 .058 0.01 .781
HCV diagnosis
Yes 0.06 0.09 < .001 0.08 < .001
No 0.94 0.91 0.92
STD diagnosis
Yes 0.04 0.06 < .001 0.06 < .001
No 0.96 0.94 0.94
History of mental illness
Yes 0.24 0.27 < .001 0.28 < .001
No 0.76 0.73 0.72
HCV hepatitis C virus, LAAM levo-α-acetylmethadol, STD sexually transmitted disease
aMean difference between clients tested for HIV and clients not tested for HIV
bChi-square test for categorical variables and t-tests for continuous variables
cMean difference between clients who received HIV test results and clients who did not receive HIV test results
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Table 2 Logistic regression on HIV testing and receipt of test results among clients in addiction health services
Independent variables HIV Testing Receipt of HIV test results
n = 89,383 n = 76,392
OR SE 99 % CI OR SE 99 % CI
Predisposing factors
Female 1.527** 0.106 1.277, 1.826 1.454** 0.123 1.169, 1.809
Age 0.998 0.001 0.994, 1.002 0.997 0.001 0.994, 1.000
Racea
Black 1.299* 0.112 1.039, 1.623 1.183 0.099 0.952, 1.468
Latino 1.126 0.058 0.987, 1.285 1.003 0.049 0.884, 1.138
Asian 0.945 0.052 0.820, 1.089 0.911 0.058 0.773, 1.074
Educationb
High school 1.434** 0.121 1.154, 1.782 1.336** 0.105 1.090, 1.636
College or higher 1.991** 0.163 1.613, 2.457 1.930** 0.141 1.598, 2.331
Homeless 1.414** 0.109 1.161, 1.724 1.158 0.122 0.882, 1.519
Referralc
Community 1.146 0.144 0.829, 1.584 1.225 0.168 0.860, 1.746
Proposition 36 1.388* 0.160 1.032, 1.866 1.354 0.169 0.980, 1.869
Drug court 1.225 0.217 0.777, 1.933 1.307 0.238 0.818, 2.089
Social services 1.282 0.143 0.961, 1.710 1.215 0.232 0.743, 1.987
Days incarcerated 1.010 0.006 0.995, 1.024 1.005 0.005 0.992, 1.019
Recovery support 1.039** 0.004 1.029, 1.049 1.034** 0.004 1.023, 1.045
Enabling factors
Employed at admission 1.174* 0.070 1.006, 1.370 1.241** 0.079 1.055, 1.461
Days on waiting list 0.998 0.007 0.981, 1.015 0.993 0.005 0.979, 1.006
Treatment typed
Methadone 0.478 0.272 0.111, 2.069 0.612 0.344 0.144, 2.601
Residential 1.738** 0.263 1.177, 2.565 1.672* 0.306 1.044, 2.680
Prior treatment episodes 1.069** 0.019 1.022, 1.118 1.048** 0.014 1.013, 1.083
Medication
None
Methadone/LAAM 1.144 0.150 0.817, 1.603 1.754** 0.302 1.126, 2.733
Buprenorphine 1.220 0.113 0.962, 1.548 1.428 0.226 0.949, 2.146
Other 1.598* 0.291 1.000, 2.554 1.288 0.434 0.541, 3.069
Outpatient medical visits 1.000 0.005 0.986, 1.014 0.994 0.008 0.972, 1.015
Outpatient psychiatric visits 0.992 0.008 0.973, 1.012 0.981 0.009 0.959, 1.004
Need factors
Primary druge
Alcohol 0.783 0.081 0.600, 1.020 1.018 0.119 0.754, 1.375
Methamphetamine 1.023 0.072 0.853, 1.226 1.189 0.127 0.902, 1.566
Cocaine or crack 0.889 0.068 0.730, 1.083 1.069 0.116 0.808, 1.413
Marijuana or hashish 0.753** 0.051 0.632, 0.897 0.897 0.090 0.693, 1.163
Other 0.961 0.078 0.780, 1.184 1.238 0.128 0.948, 1.617
Days of primary drug use 1.003 0.003 0.996, 1.010 1.002 0.003 0.993, 1.011
Method of drug usef
Smoking 1.080 0.079 0.894, 1.306 1.165 0.073 0.992, 1.368
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99 % CI = 1.032, 1.866) or social services (OR = 1.282,
CI = 0.961, 1.710); and had recovery support (OR = 1.039,
99 % CI = 1.029, 1.049).
Enabling factors
The subsample that reported HIV testing also reported
more days on a waiting list, more treatment episodes,
and more outpatient medical and psychiatric visits. This
subsample also reported a higher proportion of clients
in residential treatment, a lower proportion of outpatient
and methadone treatment, and less use of methadone
and other medications (see Table 1).
Hypothesis 2a was supported, i.e., enabling factors were
associated with higher odds of HIV testing (see Table 2).
The odds of receiving HIV testing were higher among cli-
ents who were employed at admission (OR = 1.174, 99 %
CI = 1.006, 1.370) and had prior treatment episodes
(OR = 1.069, 99 % CI = 1.022, 1.118) after adjusting for
other explanatory variables. In addition, clients in residen-
tial treatment had higher odds of receiving HIV testing
compared to other treatment types (OR = 1.738, 99 %
CI = 1.177, 2.565). Last, clients receiving buprenorphine
medication had higher odds of receiving HIV testing when
compared to other medication use (OR = 1.220, 99 %
CI = 0.962, 1.548).
Need factors
Individuals who reported HIV testing had higher pro-
portions of heroin, methamphetamine, and cocaine use
and a higher rate of injection as the method of drug use.
This sample reported less use of alcohol and marijuana.
This sample also reported higher rates of HCV, STD,
and history of mental illness (see Table 1).
Partial support was found for Hypothesis 3a, i.e., some
need factors were associated with higher odds of HIV
(see Table 2). The odds of HIV testing among clients
whose primary drug was alcohol or marijuana were sig-
nificantly lower relative to heroin (OR = 0.783, 99 %
CI = 0.601, 1.021 and OR = 0.753, 99 % CI = 0.632, 0.897,
respectively). Inhalation (OR = 1.217, 99 % CI = 0.982,
1.509) and injection (OR = 1.389, 99 % CI = 1.095, 1.762)
as methods of drug use were associated with higher odds
of receiving HIV testing relative to oral drug use. Last,
the odds of HIV testing were higher for individuals with
a history of mental illness (OR = 1.487, 99 % CI = 1.206,
1.834), more than twice as high for individuals with a
HCV diagnosis (OR = 2.346, 99 % CI = 1.568, 3.510), and
more than 3 times as high for individuals with a STD
diagnosis (OR = 3.403, 99 % CI = 2.435, 4.756), relative to
their counterparts with no history of mental illness, no
HCV diagnosis, and no STD diagnosis, respectively.
Receipt of HIV test results
Predisposing factors
Clients reporting receipt of HIV test results had a higher
proportion of women, Whites, college-educated individ-
uals, homeless individuals, and clients referred by social
services (see Table 1).
Hypothesis 1b was partially supported, i.e., some pre-
disposing factors were associated with lower odds of re-
ceipt of HIV test results, as presented in Table 2. The
odds of receipt of HIV test results decreased with age
(OR = 0.997, 99 % CI = 0.994, 1.000). However, odds of
receiving HIV test results were higher among women
(OR = 1.454, 99 % CI = 1.169, 1.809), Blacks (OR = 1.183,
99 % CI = 0.952, 1.468), college-educated individuals
(OR = 1.930, 99 % CI = 1.598, 2.331), and clients who
had recovery support (OR = 1.034, 99 % CI = 1.023,
1.045). Last, the odds of receipt of HIV test results were
higher for clients who received a Proposition 36 referral
compared to other referral sources (OR = 1.354, 99 %
CI = 1.023, 1.450).
Enabling factors
Clients who received HIV test results also reported more
days on a waiting list, more treatment episodes, more
Table 2 Logistic regression on HIV testing and receipt of test results among clients in addiction health services (Continued)
Inhalation 1.217 0.101 0.982, 1.509 1.225* 0.089 1.016, 1.476
Injection 1.389** 0.128 1.095, 1.762 1.602** 0.155 1.248, 2.057
Other 1.285 0.260 0.763, 2.164 1.133 0.235 0.664, 1.932
Days of injection drug use 1.003 0.005 0.992, 1.015 0.991 0.006 0.975, 1.007
HCV diagnosis 2.346** 0.367 1.568, 3.510 1.632** 0.206 1.180, 2.258
STD diagnosis 3.403** 0.442 2.435, 4.756 2.535** 0.333 1.807, 3.555
History of mental illness 1.487** 0.121 1.206, 1.834 1.518** 0.140 1.198, 1.925
CI confidence interval, HCV hepatitis C virus, LAAM levo-α-acetylmethadol, STD sexually transmitted disease
aWhite was reference group
bLess than high school was reference group
cSelf-referral was reference group
dOutpatient treatment was reference group
eHeroin was reference group
fOral was reference group
*p < .01. **p < .001
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outpatient medical and psychiatric visits, an increased
likelihood of being in residential treatment, and a lower
likelihood of receiving outpatient and methadone treat-
ment. This sample also reported less use of methadone
and other medications (see Table 1).
Partial support was found for Hypothesis 2b, i.e., some
predisposing factors were associated with higher odds of
receipt of HIV test results (see Table 2). The odds of re-
ceipt of HIV test results were higher among clients who
were employed at admission (OR = 1.241, 99 % CI = 1.055,
1.461) and had prior treatment episodes (OR = 1.048, 99 %
CI = 1.013, 1.083). However, more outpatient psychiatric
visits resulted in lower odds of receipt of HIV test results
(OR = 0.981, CI = 0.959, 1.004). In addition, clients in resi-
dential treatment had higher odds of receiving HIV test
results compared to other treatment types (OR = 1.672,
99 % CI = 1.044, 2.680). Last, clients using methadone and
buprenorphine medication had higher odds of receiving
HIV test results when compared to other medications
(OR = 1.754, 99 % CI = 1.126, 2.733 and OR = 1.428, 99 %
CI = 0.949, 2.146, respectively).
Need factors
Relative to the full sample, individuals who received HIV
test results reported higher proportions of heroin, meth-
amphetamine, and cocaine use and a higher rate of in-
jection as the method of drug use. This sample reported
less use of alcohol and marijuana. This sample also re-
ported higher rates of HCV, STD, and history of mental
illness (see Table 1).
Partial support was found for Hypothesis 3b, i.e., some
need factors were associated with higher odds of receipt
of HIV test results (see Table 2). Smoking (OR = 1.165,
99 % CI = 0.992, 1.368), inhalation (OR = 1.225, 99 %
CI = 1.016, 1.476), and injection (OR = 1.602, 99 %
CI = 1.248, 2.057) as methods of drug use resulted in
higher odds of receiving HIV test results. Last, the odds
of receipt of HIV test results were higher among clients
with a history of mental illness (OR = 1.518, 99 %
CI = 1.198, 1.925), HCV diagnosis (OR = 1.632, 99 %
CI = 1.180, 2.258), and STD diagnosis (OR = 2.535, 99 %
CI = 1.807, 3.555).
Discussion
Using data from Los Angeles County, we found that des-
pite federal efforts by regulatory agencies such as the
CDC to increase HIV testing and receipt of test results
among high-risk populations, only 64 % of clients of one
of the largest addiction health services programs re-
ported being tested for HIV. Among those tested, how-
ever, 85 % reported receiving their test results. These
results illustrate the need for programs that further
emphasize testing and awareness of HIV status among
clients of addiction health services. The high proportion
of clients receiving test results suggests that there may
be client and program factors facilitating awareness of
HIV status.
Guided by the Gelberg-Anderson model, we tested the
extent to which predisposing, enabling, and need factors
were associated with HIV testing and receipt of HIV test
results. Except for Hypothesis 1a, findings lent partial
support to all hypotheses tested. Overall, predisposing
factors were not associated with lower odds of HIV test-
ing. Contrary to our hypothesis, the odds of HIV testing
were higher among women, Blacks, and Latinos com-
pared to Whites, homeless individuals, clients referred
by Proposition 36 or social services, and clients who had
recovery support. Results suggest that members of
groups that historically have faced personal and institu-
tional barriers to HIV testing [24–26] are receiving this
service in the county system.
Although many of the factors representing the areas of
the model were statistically significant, most of the ratios
were small, prompting discussion of the most relevant
factors observed. The models allowed us to discuss these
factors by conceptual category, but it is also worth
highlighting the most relevant individual factors associ-
ated with potential interventions. Among these factors
was the role of age in decreased odds of receipt of HIV
test results, whereas vulnerable populations like women,
Blacks, and individuals with recovery support showed
higher odds of HIV testing. Unlike in other studies, in
Los Angeles County we found that racial and ethnic mi-
norities are more likely than Whites to access HIV
testing-related services. Although low-income racial and
ethnic minorities and homeless individuals are at a dis-
advantage in terms of accessing HIV care and adhering
to care recommendations [25, 26], there may be other
factors, as suggested by our findings, that moderate
these relationships. Vulnerable populations may have
competing circumstances that may hinder testing, yet
they may also have access to or be enrolled in programs
with requirements (e.g., CalWorks welfare program,
criminal justice system) that may facilitate testing and
receipt of test results. These findings are also in line with
studies that have shown that individuals at high risk of
HIV infection as a function of their sociodemographics
[43–45] and those who often engage in health and social
services programs [46–48] are more likely to be tested.
A possible implication of this finding is that targeting
and reaching clients who may be in need of HIV testing
is complex, and cannot be determined by one element of
vulnerability. Multiple levels of data and knowledge, in-
cluding program, geographic, and community, may be
essential to developing effective interventions.
In contrast, most enabling factors were associated with
higher odds of HIV testing and receipt of test results as
hypothesized. As proposed, more interactions with care
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providers and access to employment and other health
care services may increase opportunities for HIV testing
and receipt of results. Findings showed that employment
at admission, prior treatment episodes, residential treat-
ment, and use of buprenorphine medication was associ-
ated with higher odds of both HIV testing and receipt of
test results. It is important to note that private providers
mostly prescribe buprenorphine, which may be a reflec-
tion of the socioeconomic status of clients who receive
HIV testing. However, our findings are consistent with
studies that have shown that access to comprehensive
services and employment opportunities [44, 45, 49], as
well as engagement with the health care system may
present opportunities for HIV testing and awareness of
HIV status [50–53]. Improving economic conditions, for
example, has been associated with increased uptake of
HIV testing [50, 54]. Additionally, previous encounters
with treatment providers may present opportunities for
education and prevention activities that are effective in
increasing HIV testing [50, 51].
Need factors were also associated with higher odds of
HIV testing and receipt of test results. Clients’ increased
knowledge of risk factors for conditions such as HIV
may increase the odds of testing and securing test re-
sults. Higher odds of HIV testing were found among cli-
ents whose primary drug of choice was alcohol or
marijuana, whose method of drug use was inhalation or
injection, and who had a history of mental illness or
HCV or STD diagnoses. As for higher odds of receipt of
test results, except for smoking, all other previously
mentioned factors related to HIV testing were also posi-
tively related to receipt of test results. Overall, need and
enabling factors related to clients with comorbidities or
other conditions that may relate to HIV were associated
with testing and receipt of results.
Although application of the Gelberg-Anderson model
can include a wide array of client and provider factors
that may be difficult to disentangle (e.g., use of medica-
tion, referral source, etc.) [18], it provided a critical
framework to organize our findings and may inform
comprehensive interventions for systems delivering care
to specific vulnerable groups. Our results suggest a set
of gender, race, psychosocial stressors, and drug-related
conditions that may enable or inhibit HIV testing and
obtaining test results. Findings from this analysis may
inform the development of effective strategies to in-
crease HIV testing and awareness of infection status
among populations for whom interventions would be
useful, including clients with several predisposing factors
and limited enabling factors. Identifying client factors as-
sociated with HIV testing and receipt of results is also
essential to improving HIV testing practices, increasing
awareness of HIV status, initiating early linkage to treat-
ment, and improving patient outcomes. Overall, our
findings are important for public health because they
may inform HIV testing practices and increase aware-
ness of infection status among mostly low-income and
culturally diverse clients engaged in one of the largest
publicly funded addiction health services systems in the
United States.
Limitations
There are several important limitations of the study.
Although members of one of the most populous and
racially and ethnically diverse populations in the nation,
individuals in this study represented only one county in
California. Characteristics associated with HIV testing
and receipt of testing results among individuals in sub-
stance use disorder treatment may differ nationally and
regionally. The current analysis also focused on HIV
testing prior to entering treatment. Future research
should include a longer time period. Additionally, due
to lack of data, we could not verify the accuracy of data
on HIV testing or receipt of test results. Access to med-
ical records would have allowed us to match adminis-
trative data with clinical records to determine whether
a client was ever tested for HIV. Similarly, review of
medical records may have provided information regard-
ing whether a client was offered posttest counseling
and referred to treatment or provided information on
how to remain HIV negative. Last, we could not deter-
mine from the available data whether clients were
offered and refused HIV testing. The data were limited
regarding the availability of information about system-
level factors (e.g., funding, regulation, and service infra-
structure) of critical importance to delivering HIV
testing and communicating results. However, these
robust findings, based on 4 years of data from Los
Angeles County, are important because they suggest
identifiable characteristics that can be targeted to reduce
the risk and spread of HIV infection among the most
high-risk populations, particularly clients of addiction
health services.
Conclusion
Our findings highlight important factors that may be
useful in helping substance use disorder treatment pro-
grams increase HIV testing rates, promote awareness of
infection status, and prevent HIV infection and trans-
mission. These findings are partly supported by prior
studies [2, 14, 24, 26] that identified conditions associ-
ated with HIV testing in health care settings. Because
client demographics, sociocultural characteristics, and
provider conditions play a role in the extent to which
clients receive HIV testing and obtain test results, it is
critical to build on this preliminary analysis of key fac-
tors to develop longitudinal studies to assess risk and
likelihood of testing. Examining these factors in one of
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the largest publicly funded treatment systems in the
United States is of critical importance to identifying po-
tential factors and target populations and developing
strategies to increase access to and uptake of HIV testing
and awareness of HIV status while decreasing the bur-
den of HIV in populations at higher risk of contracting
and spreading the disease.
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